Psoriasis

Dangers, Benefits of Biologics Must Be Carefully Weighed
June 15, 2021

Biologic therapy has proven very useful in treating an increasing number of dermatologic diseases and conditions. However, caution is warranted for patients with chronic infectious diseases.

Secukinumab Approved for Plaque Psoriasis in Children, Adolescents
June 11, 2021

John Browning, MD, FAAD, FAAP, MBA, discusses the impact of the recent FDA approval of secukinumab (Cosentyx, Novartis) for the treatment of moderate to severe plaque psoriasis in children and adolescents.

Tapinarof Cream Submitted for Approval for Treatment of Plaque Psoriasis
June 04, 2021

Dermavant has submitted a New Drug Application (NDA) to the FDA seeking approval for its novel topical for the treatment of mild, moderate, and severe plaque psoriasis in adult patients.